Myriad Genetics received approval for a diagnostic test aimed at identifying advanced ovarian cancer patients eligible for treatment with Zejula from the Food and Drug Administration. The diagnostic ...

Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...

The actress, who underwent the serious surgery last year, appeared on the show to chat to Jon Kay, 56, and Sally Nugent, 54, ...

Menopause is a natural life stage, however, it brings hormonal shifts that may influence cancer risk. Oncologist says awareness, screening and positive lifestyle choices help women over 45 to protect ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

A teacher said she is "facing a death sentence" after battling a form of cancer known as the silent killer. Emma Durkin was ...

Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from Cancer Research UK, between 2022 and 2024, around 247 people per 100,000 ...

Young patients often struggle to get early diagnosis of cancer leading to delays and more advanced stages of disease.

An ovarian cancer survivor reflects on community, advocacy, and living a life shaped by purpose—not just diagnosis.

BRCA gene mutations can significantly raise a woman’s risk of breast and ovarian cancer. Know how hereditary cancer risk works and why genetic testing and early screening matter.